UK Approves Merck's Hypertension Drug Acquired Via $11 Billion Acceleron Pharma Deal
Last Friday, the Medicines and Healthcare Products Regulatory Agency approved Merck & Co Inc’s (NYSE:MRK) Winrevair ...
FiercePharma2 小时
Regulatory tracker: Merck's blockbuster hopeful Winrevair snags PAH approval in UK
Welcome to Fierce Pharma's regulatory tracker for the first half of 2025. | In this tracker, Fierce Pharma is recording the ...
pulmonologyadvisor5 小时
Link Found Between IFI16 Induction and Endothelial Inflammation in PAH
IFI16 facilitates the inflammatory endothelial pathophenotypes observed among individuals with PAH, according to new research ...
UK MHRA approves MSD’s pulmonary arterial hypertension therapy
MSD has received the UK Medicines and Healthcare products Regulatory Agency (MHRA) approval for sotatercept, marketed as ...
Stocktwits on MSN10 小时
Merck Stock In Focus After Regulatory Approval For PAH Drug: Retail Sentiment Brightens
Shares of Merck & Co. Inc ($MRK) were in the spotlight this week after the pharmaceutical major secured regulatory approval ...
Business Insider13 小时
KROS ALERT- Levi & Korsinsky Has Commenced an Investigation on Behalf of Keros Therapeutics ...
Keros issued a press release on December 12, 2024, "announc[ing] that it has voluntarily halted dosing in the 3.0 mg/kg and 4.5 mg/kg treatment arms in the ongoing TROPOS trial, a Phase 2 clinical ...
BioSpace20 小时
2024 Ends With Greenlights for Merck’s PAH Drug in UK and BMS’ Opdivo Injection in US
On Tuesday, the UK’s Medicines and Healthcare products Regulatory Agency approved Winrevair (sotatercept) for pulmonary ...